Lin W.Y., Lin C.P., Yeh S.J., Hsieh B.T., Tsai Z.T., Ting G., Yen T.C., Wang S.J.,
Knapp F.F., Stabin M.G.
Rhenium 188 hydroxyethylidene diphosphonate: a new genera
tor produced radiotherapeutic drug of potential value for the treatment of bone metastases
// Eur. J. Nucl. Med.. — 1997. — V. 24(6). — P. 590 595.
Linden J.C., Baak J.P.A., Postma T.
è ñîàâò. Monitoring serumCEA in women with
primary breast tumours positive for oestrogen receptor and with spread to lympth node //
J. Clin. Patthol. — 1985. — V.38(11). — P. 1229 1234.
Link T.M., Sciuk J., Frundt H., Konermann W., Schober O., Peters P.E.
Spinal
metastases. Value of diagnostic procedures in the initial diagnosis and follow up //
Radiologe. — 1995. — V. 35(1). — P. 21 27.
Lipman A.G.
Clinically relevant differnces among the opioid analgesics // Am. J.
Hosp. Pharm. — 1990. — V.47(8) — P.7 13.
Lipton A., Harvey H.A., Santen R.J., Boucher A., White D., Bernath A., Dixon R.
Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer //
Cancer Res. — 1982. — V. 42( 8). — P. 3434 3436.
Lipton A., Costa L., Demers L.M.
Bone markers in osteoporosis and malignancy //
Can .J. Oncol. — 1995. — V. 5 (Suppl. 1). — P. 11 15.
Lipton A.
Bisphosphonates and breast carcinoma //Cancer.—1997.—V. 80(Suppl. 8). —
P. 1668 1673.
Lipton A., Demers L., Curley E., Chinchilli V., Gaydos L., Hortobagyi G., Theriault R.,
Clemens D., Costa L., Seaman J., Knight R.
Markers of bone resorption in patients treated
with pamidronate // Eur. J. Cancer. — 1998. — V. 34(13). — P. 2021 2026.
Lipton A., Berenson J.R.
Bisphosphonate treatment of lytic bone metastases // Drugs
Aging. — 1999. — V. 14(4). — P. 241 246.
Lissoni P., Cazzaniga M., Barni S., Perego M.S., Brivio F., Fumagalli L., Tancini G.
Acute effects of pamidronate administration on serum levels of interleukin 6 in advanced
solid tumour patients with bone metastases and their possible implications in the
immunotherapy of cancer with interleukin 2 // Eur. J. Cancer. — 1997. — V. 33(2). —
P. 304 306.
Livingston R.B., Ellis G.K., Gralow J.R.,
è ñîàâò. Dose intensive vinorelbine with
concurrent granulocyte colony stimulating factor support in paclitaxel refractory metasta
tic breast cancer // J. Clin. Oncol. — 1997. — V. 15. — P. 1395 1400.
Lloyd R.E., Jones S.E., Salmon S.E.
Comparative trial of low dose adriamycin plus
cyclophsphamide with or without additive hormonal therapy in advanced breast cancer //
Cancer. — 1979. — V. 43. — P.60 65.
Lodwick G.S.
Reactive response to local injury in bone // Radiol. Clin. North Am. —
1964. — V. 2. — P. 209 219.
Logroscino C.A., Paliotta V.F., Specchia N.
Surgical stabilisation of spinal malignant
tumors // Department of Orthopeaedics, Division for spinal Surgery, Catholicle
University of Rome. — 1997.
Lonning P.E., Bajetta E., Murray R.,
è ñîàâò. A phase II study of exemestane (EXE)
in metastatic breast cancer (MBC) patients failing non steroidal aromatase inhibitors //
Breast Cancer Res. Treat. — 1998. — V. 50. — P. 304.
Loprinzi C.L., Tormey D.C., Rasmussen P.
è ñîàâò. Prospective evalution of carci
noembryonic antigen levels and alternating chemotherapeutic regimens in metastatic
breast cancer // J. Clin. Oncol. — 1986. — V. 4. — P.46 56.
Lovera C., Massardo T., Galleguillos M.C., Gonzalez P., Comparini B., Yanez M.,
Fodor M., Gil M.C., Araya G., Tomicic M.
Analgesic response and secondary effects in
236
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
